Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

TD Cowen

since

auto-detected in 19 stories

4 days ago

TD Cowen is initiating coverage on four crypto treasury firms – public companies who make it their job to buy and hold crypto to increase shareholder value.

22 days ago

TD Cowen reiterated a buy rating on Blue Owl Capital, while lowering its 12-month price target to $14 from $16, according to a report out Monday.

35 days ago

Rivian Automotive's upcoming R2 model could capitalize on an electric vehicle demand rebound in the U.S., according to TD Cowen.

5 months ago

Analyst Moshe Orenbuch upgraded the stock to buy from hold.

6 months ago

There may be more upside ahead from AMD's partnership with OpenAI, according to TD Cowen.
A protracted impasse could crimp backlog conversion, slow awards and weigh on cash flow for government services firms, according to TD Cowen.
The latest rally in shares of Warner Bros. Discovery may not hold if a takeover bid from Paramount Skydance doesn't come to fruition, TD Cowen said this week.

8 months ago

AbbVie, Bristol Myers Squibb and Eli Lilly appear "relatively well-positioned," while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said.
TD Cowen upgraded the investment management stock to buy from hold.

page 1 of 2 last →|